Exploration of plasma biomarkers for Alzheimer’s disease by targeted lipid metabolomics based on nuclear magnetic resonance (NMR) spectroscopy

An Y, Zhang X, Wang Y, Wang Y, Liu W, Wang T, Qin Z, Xiao R (2019) Longitudinal and nonlinear relations of dietary and serum cholesterol in midlife with cognitive decline: results from EMCOA study. Mol Neurodegeneration 14(1):51. https://doi.org/10.1186/s13024-019-0353-1

Article  CAS  Google Scholar 

Ancelin ML, Ripoche E, Dupuy AM, Barberger-Gateau P, Auriacombe S, Rouaud O, Berr C, Carrière I, Ritchie K (2013) Sex differences in the associations between lipid levels and incident dementia. J Alzheimer’s Disease: JAD 34(2):519–528. https://doi.org/10.3233/jad-121228

Article  CAS  PubMed  Google Scholar 

Bailey-Downs LC, Tucsek Z, Toth P, Sosnowska D, Gautam T, Sonntag WE, Csiszar A, Ungvari Z (2013) Aging exacerbates obesity-induced oxidative stress and inflammation in perivascular adipose tissue in mice: a paracrine mechanism contributing to vascular redox dysregulation and inflammation. The journals of gerontology Series A, Biological sciences and medical sciences. 68(7):780–792. https://doi.org/10.1093/gerona/gls238

Barupal DK, Baillie R, Fan S, Saykin AJ, Meikle PJ, Arnold M, Nho K, Fiehn O, Kaddurah-Daouk R (2019) Sets of coregulated serum lipids are associated with Alzheimer’s disease pathophysiology. Alzheimer’s Dement (Amsterdam Netherlands) 11:619–627. https://doi.org/10.1016/j.dadm.2019.07.002

Article  Google Scholar 

Beckonert O, Keun HC, Ebbels TM, Bundy J, Holmes E, Lindon JC, Nicholson JK (2007) Metabolic profiling, metabolomic and metabonomic procedures for NMR spectroscopy of urine, plasma, serum and tissue extracts. Nat Protoc 2(11):2692–2703. https://doi.org/10.1038/nprot.2007.376

Article  CAS  PubMed  Google Scholar 

Bell RD, Deane R, Chow N, Long X, Sagare A, Singh I, Streb JW, Guo H, Rubio A, Van Nostrand W, Miano JM, Zlokovic BV (2009) SRF and myocardin regulate LRP-mediated amyloid-beta clearance in brain vascular cells. Nat Cell Biol 11(2):143–153. https://doi.org/10.1038/ncb1819

Article  CAS  PubMed  Google Scholar 

Berezhnoy G, Laske C, Trautwein C (2022) Quantitative NMR-Based Lipoprotein Analysis Identifies Elevated HDL-4 and Triglycerides in the Serum of Alzheimer’s Disease Patients. Int J Mol Sci 23(20). https://doi.org/10.3390/ijms232012472

de Oliveira FF, Chen ES, Smith MC, Bertolucci PHF (2017) Longitudinal lipid profile variations and clinical change in Alzheimer’s disease dementia. Neurosci Lett 646:36–42. https://doi.org/10.1016/j.neulet.2017.03.003

Article  CAS  PubMed  Google Scholar 

Dona AC, Jiménez B, Schäfer H, Humpfer E, Spraul M, Lewis MR, Pearce JT, Holmes E, Lindon JC, Nicholson JK (2014) Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping. Anal Chem 86(19):9887–9894. https://doi.org/10.1021/ac5025039

Article  CAS  PubMed  Google Scholar 

Ferretti MT, Bruno MA, Ducatenzeiler A, Klein WL, Cuello AC (2012) Intracellular Aβ-oligomers and early inflammation in a model of Alzheimer’s disease. Neurobiol Aging 33(7):1329–1342. https://doi.org/10.1016/j.neurobiolaging.2011.01.007

Article  CAS  PubMed  Google Scholar 

Folstein MF, Folstein SE, McHugh PR (1975) Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12(3):189–198. https://doi.org/10.1016/0022-3956(75)90026-6

Article  CAS  PubMed  Google Scholar 

Fujiyoshi M, Tachikawa M, Ohtsuki S, Ito S, Uchida Y, Akanuma S, Kamiie J, Hashimoto T, Hosoya K, Iwatsubo T, Terasaki T (2011) Amyloid-β peptide(1–40) elimination from cerebrospinal fluid involves low-density lipoprotein receptor-related protein 1 at the blood-cerebrospinal fluid barrier. J Neurochem 118(3):407–415. https://doi.org/10.1111/j.1471-4159.2011.07311.x

Article  CAS  PubMed  Google Scholar 

Gan M, Jiang P, McLean P, Kanekiyo T, Bu G (2014) Low-density lipoprotein receptor-related protein 1 (LRP1) regulates the stability and function of GluA1 α-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA) receptor in neurons. PLoS ONE 9(12):e113237. https://doi.org/10.1371/journal.pone.0113237

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ganz P, Heidecker B, Hveem K, Jonasson C, Kato S, Segal MR, Sterling DG, Williams SA (2016) Development and validation of a protein-based risk score for Cardiovascular outcomes among patients with stable Coronary Heart Disease. JAMA 315(23):2532–2541. https://doi.org/10.1001/jama.2016.5951

Article  CAS  PubMed  Google Scholar 

Grossi MF, Carvalho MDG, Silveira JN, Gonçalves GS, Gomes KB, Bicalho MA, Silva IFO (2018) OxLDL plasma levels in patients with Alzheimer’s disease. Arq Neuropsiquiatr 76(4):241–246. https://doi.org/10.1590/0004-282x20180012

Article  PubMed  Google Scholar 

Jeyarajah EJ, Cromwell WC, Otvos JD (2006) Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy. Clin Lab Med 26(4):847–870. https://doi.org/10.1016/j.cll.2006.07.006

Article  PubMed  Google Scholar 

Ji Y, Liu M, Huo YR, Liu S, Shi Z, Liu S, Wisniewski T, Wang J (2013) Apolipoprotein Ε ε4 frequency is increased among Chinese patients with frontotemporal dementia and Alzheimer’s disease. Dement Geriatr Cogn Disord 36(3–4):163–170. https://doi.org/10.1159/000350872

Article  CAS  PubMed  Google Scholar 

Jiang Y, Zhou X, Ip FC, Chan P, Chen Y, Lai NCH, Cheung K, Lo RMN, Tong EPS, Wong BWY, Chan ALT, Mok VCT, Kwok TCY, Mok KY, Hardy J, Zetterberg H, Fu AKY, Ip NY (2022) Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer’s disease screening and staging. Alzheimers Dement 18(1):88–102. https://doi.org/10.1002/alz.12369

Article  CAS  PubMed  Google Scholar 

Jiménez B, Holmes E, Heude C, Tolson RF, Harvey N, Lodge SL, Chetwynd AJ, Cannet C, Fang F, Pearce JTM, Lewis MR, Viant MR, Lindon JC, Spraul M, Schäfer H, Nicholson JK (2018) Quantitative lipoprotein subclass and Low Molecular Weight Metabolite Analysis in Human serum and plasma by (1)H NMR spectroscopy in a Multilaboratory Trial. Anal Chem 90(20):11962–11971. https://doi.org/10.1021/acs.analchem.8b02412

Article  CAS  PubMed  Google Scholar 

Johnson CH, Ivanisevic J, Siuzdak G (2016) Metabolomics: beyond biomarkers and towards mechanisms. Nat Rev Mol Cell Biol 17(7):451–459. https://doi.org/10.1038/nrm.2016.25

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jones L, Harold D, Williams J (2010) Genetic evidence for the involvement of lipid metabolism in Alzheimer’s disease. Biochim Biophys Acta 1801(8):754–761. https://doi.org/10.1016/j.bbalip.2010.04.005

Article  CAS  PubMed  Google Scholar 

Kalecký K, German DC, Montillo AA, Bottiglieri T (2022) Targeted metabolomic analysis in Alzheimer’s Disease plasma and brain tissue in non-hispanic whites. J Alzheimers Dis 86(4):1875–1895. https://doi.org/10.3233/jad-215448

Article  PubMed  PubMed Central  Google Scholar 

Kanekiyo T, Liu CC, Shinohara M, Li J, Bu G (2012) LRP1 in brain vascular smooth muscle cells mediates local clearance of Alzheimer’s amyloid-β. J Neuroscience: Official J Soc Neurosci 32(46):16458–16465. https://doi.org/10.1523/jneurosci.3987-12.2012

Article  CAS  Google Scholar 

Kawade N, Yamanaka K (2023) Novel insights into brain lipid metabolism in Alzheimer’s disease: oligodendrocytes and white matter abnormalities. FEBS open bio. https://doi.org/10.1002/2211-5463.13661

Article  PubMed  PubMed Central  Google Scholar 

Lehallier B, Gate D, Schaum N, Nanasi T, Lee SE, Yousef H, Moran Losada P, Berdnik D, Keller A, Verghese J, Sathyan S, Franceschi C, Milman S, Barzilai N, Wyss-Coray T (2019) Undulating changes in human plasma proteome profiles across the lifespan. Nat Med 25(12):1843–1850. https://doi.org/10.1038/s41591-019-0673-2

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lista S, Faltraco F, Prvulovic D, Hampel H (2013) Blood and plasma-based proteomic biomarker research in Alzheimer’s disease. Prog Neurobiol 101–102:1–17. https://doi.org/10.1016/j.pneurobio.2012.06.007

Article  CAS  PubMed  Google Scholar 

Liu Q, Zhang J, Zerbinatti C, Zhan Y, Kolber BJ, Herz J, Muglia LJ, Bu G (2011) Lipoprotein receptor LRP1 regulates leptin signaling and energy homeostasis in the adult central nervous system. PLoS Biol 9(1):e1000575. https://doi.org/10.1371/journal.pbio.1000575

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu CC, Hu J, Tsai CW, Yue M, Melrose HL, Kanekiyo T, Bu G (2015) Neuronal LRP1 regulates glucose metabolism and insulin signaling in the brain. J Neuroscience: Official J Soc Neurosci 35(14):5851–5859. https://doi.org/10.1523/jneurosci.5180-14.2015

Article  CAS 

留言 (0)

沒有登入
gif